What are the BENEFITS of Carrier Genetic Test?
Carrier Genetic Test (CGT) provides information to assits in preconception planning and prenatal diagnostic testing for couples identified as carriers.
if both partners are found to be carriers for the same recessive disorder, then prenatal testing such, as CVS (chorionic villus sampling or amniocentesis, could determine if the baby is affected with the recessive disorder. This will guide the couple to make an informed decision on the current or future pregnancies)
Additionally, IVF (in-vitro fertilisation) with PGT-M (preimplantation genetic testing-Monogenic) can be considered to eliminate the risk of having an affected child.
FOCUS CGT (7 genes)
- HBA1, HBA2 (Alpha-Thalassaemia)
- HBB (Beta-Thalassaemia)
- SMN1, SMN2 (Spinal Muscular Atrophy)
- G6PD (Glucose-6-Phosphate Dehydrogenase)
- FMR1 (Fragile-X Syndrome)
EXPANDED CGT (420 genes)
- For Individuals and Couples who are considering Family Planning.
- Not specific to any one population or ethnicity, although some diseases are more common certain ethnic groups
- Some of the the more prominent genes apart from those mentioned in FOCUS CGT are:
GBA, CFTR, ATP7B, DHCR7, GAA, DMD etc.
Recommended For
- Individual & Couples Before or In Early Pregnancy
- Individuals & Couples With or Without Family History of Genetic Diseases
- Maximises the Detection of At-Risk Couples of an affected pregnancy by Inherited conditions
- Consanguineous couples
- Ethnicities with High Incidence of Genetic Diseases
According to the American College of Obstetricians and Gynecologists (ACOG),
pregnant woman and women considering pregnancy should be offered Carrier Genetic Screening.
Individuals planning to become egg or sperm donors may be offered this Carrier Screening as well.
